US 3308297A
· Mansker
· 1967
[cited by applicant]
US 3984696A
· Collica et al.
· 1976
[cited by applicant]
US 4254341A
· Herr et al.
· 1981
[cited by applicant]
US 4280056A
· Renshaw
· 1981
[cited by applicant]
US 4581538A
· Lenhart
· 1986
[cited by applicant]
US D300945S
· Fleming et al.
· 1989
[cited by applicant]
US 4923162A
· Fleming et al.
· 1990
[cited by applicant]
US 4965456A
· Huettenrauch et al.
· 1990
[cited by applicant]
US 5006718A
· Lenhart
· 1991
[cited by applicant]
US 5015864A
· Maleki
· 1991
[cited by applicant]
US 5090044A
· Kobayashi
· 1992
[cited by applicant]
US 5417225A
· Rubenstein et al.
· 1995
[cited by applicant]
US 5981964A
· McAuley et al.
· 1999
[cited by applicant]
US 6325538B1
· Heesch
· 2001
[cited by applicant]
US 6448571B1
· Goldstein
· 2002
[cited by applicant]
US 6703632B1
· Macklis et al.
· 2004
[cited by applicant]
US 7276716B1
· Munro, III
· 2007
[cited by applicant]
US 7331712B2
· Fischer et al.
· 2008
[cited by applicant]
US 7391042B2
· Goldstein
· 2008
[cited by applicant]
US 7465947B2
· Magram
· 2008
[cited by applicant]
US 7608847B2
· Rees
· 2009
[cited by applicant]
US 7638784B2
· Fox et al.
· 2009
[cited by applicant]
US 7829873B2
· Fox et al.
· 2010
[cited by applicant]
US 7973299B2
· Rees
· 2011
[cited by applicant]
US 8143607B2
· Teodorescu
· 2012
[cited by applicant]
US 8378326B2
· Hunt
· 2013
[cited by applicant]
US 8399871B2
· Beyar et al.
· 2013
[cited by applicant]
US 8439564B2
· Belson et al.
· 2013
[cited by applicant]
US 8558204B2
· Rees
· 2013
[cited by applicant]
US 8598554B2
· Rees
· 2013
[cited by applicant]
US 8683928B2
· Anderson
· 2014
[cited by applicant]
US 8716687B2
· Goldstein et al.
· 2014
[cited by applicant]
US 9349492B1
· Ganus
· 2016
[cited by applicant]
US D772414S
· Ballsieper
· 2016
[cited by applicant]
US 9867583B1
· Colling
· 2018
[cited by applicant]
US 9877688B1
· Colling
· 2018
[cited by applicant]
US 20040045557A1
· Lee
· 2004
[cited by examiner]
US 20120049093A1
· Costea
· 2012
[cited by applicant]
US 20120132217A1
· Rees
· 2012
[cited by applicant]
US 20120241652A1
· Jeschke
· 2012
[cited by applicant]
US 20120256092A1
· Zingerman
· 2012
[cited by applicant]
US 20140048730A1
· Niedzielski et al.
· 2014
[cited by applicant]
US 20150335297A1
· Mogul et al.
· 2015
[cited by applicant]
US 20160158082A1
· Gainor et al.
· 2016
[cited by applicant]
US 20190063665A1
· LeCote
· 2019
[cited by applicant]
US 20190368265A1
· Artwohl et al.
· 2019
[cited by applicant]
US 20200135355A1
· Colling
· 2020
[cited by applicant]
US 20220243864A1
· Foster et al.
· 2022
[cited by applicant]
US 20230126167A1
· Wilson et al.
· 2023
[cited by applicant]
US 20230181131A1
· Hassid
· 2023
[cited by applicant]
US 20240130698A1
· Goldstein et al.
· 2024
[cited by applicant]
US 20240335175A1
· Wilson et al.
· 2024
[cited by applicant]
US 20250032069A1
· Foster et al.
· 2025
[cited by applicant]
US 20250032070A1
· Wilson et al.
· 2025
[cited by applicant]
US 20250195017A1
· Foster et al.
· 2025
[cited by applicant]
AU 2020104005A4
· 2021
[cited by applicant]
CN 2349990
· 1999
[cited by applicant]
CN 201175342Y
· 2009
[cited by applicant]
CN 202458424U
· 2012
[cited by applicant]
CN 204066762U
· 2014
[cited by applicant]
CN 205680451U
· 2016
[cited by applicant]
CN 206151478U
· 2017
[cited by applicant]
CN 108309345A
· 2018
[cited by applicant]
CN 112716513A
· 2021
[cited by applicant]
CN 113331861A
· 2021
[cited by applicant]
CN 214157352U
· 2021
[cited by applicant]
CN 214856844U
· 2021
[cited by applicant]
CN 114587402A
· 2022
[cited by applicant]
CN 115251974A
· 2022
[cited by applicant]
CN 116058862A
· 2023
[cited by applicant]
CN 110537932B
· 2023
[cited by applicant]
CN 118280616A
· 2024
[cited by applicant]
CN 118280617A
· 2024
[cited by applicant]
DE 102014215448
· 2015
[cited by applicant]
JP 2001120543
· 2001
[cited by applicant]
JP 2009541712A
· 2009
[cited by applicant]
JP 2010230311A
· 2010
[cited by applicant]
JP 2013512745A
· 2013
[cited by applicant]
JP 2018044827A
· 2018
[cited by applicant]
JP 2020530574A
· 2020
[cited by applicant]
JP 2022529048A
· 2022
[cited by applicant]
KR 101081895
· 2011
[cited by applicant]
KR 1020170061691A
· 2017
[cited by applicant]
KR 101913840B1
· 2018
[cited by applicant]
KR 1020210027584A
· 2021
[cited by applicant]
TW 1666653
· 2019
[cited by applicant]
WO 2016090384A2
· 2016
[cited by applicant]
WO 2017116530A2
· 2017
[cited by applicant]
WO 2018109380A1
· 2018
[cited by applicant]
WO 2019216934A2
· 2019
[cited by applicant]
WO 2020163773A1
· 2020
[cited by applicant]
WO 2020214992A1
· 2020
[cited by applicant]
WO 2024056637A1
· 2024
[cited by applicant]
Aadco Medical, Inc. “Overhead Barriers” obtained from the world wide web Dec. 29, 2016; http://www.aadcomed.com/products/barriers_shields/overhead_barriers; pp. 1-4 Dec. 29, 2016.
[cited by applicant]
ASTM F3094 (ASTM International ““Standard Test Method for Determining Protection Provided by X-ray ShieldingGarments Used in Medical X-ray Fluoroscopy from Sources of Scattered X-Rays”” ASTM vol. 11.03 OccupationalHealt…
[cited by applicant]
De La Hera, German ““International Search Report—PCT/US20/17309”” Applicant—Intervention for Life, LLC; p. Apr. 20, 2020.
[cited by applicant]
Decision of Dismissal of Amendment received for Japanese Patent Application No. 2020-530444, mailed on Apr. 25, 2023, 15 pages including English translation.
[cited by applicant]
Examination Report received for Australian Patent Application No. 2018422761, mailed on May 15, 2023, 04 pages.
[cited by applicant]
Extended European Search Report received for European Patent Application No. 23196608.6, mailed on Dec. 11, 2023, 09 pages.
[cited by applicant]
Fattal, Peter, et al. “A Novel Complete Radiation Protection System Eliminates Physician Radiation Exposure and Leaded Aprons” Catheterization and Cardiovascular Interventions 81:11-16 (2013) pp. 1-6.
[cited by applicant]
First Substantive Examination Report received for Saudi Arabia Application No. 521422707, mailed on Jun. 24, 2023, 18 pages including English translation.
[cited by applicant]
IEC 61331-1 (International Electrotechnical Commission, “Protective devices against diagnostic medical X-radiation Part 1: Determination of attenuation properties of materials” (2014).
[cited by applicant]
International Preliminary Report on Patentability received for International Application No. PCT/US2020/017309, mailed on Aug. 19, 2021, 10 pages.
[cited by applicant]
International Preliminary Report on Patentability received for International Patent Application No. PCT/US2020/028825, mailed on Oct. 28, 2021, 08 pages.
[cited by applicant]
International Preliminary Report on Patentability received for International Patent Application No. PCT/US2018/046318, mailed on Feb. 20, 2022, 10 pages.
[cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2018/046318, mailed on Nov. 12, 2019, 13 pages.
[cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2020/028825, mailed on Aug. 5, 2020, 10 pages.
[cited by applicant]
Kenex Co. Lower body x-ray shield 312/E-010; obtained from world wide web Dec. 29, 2016; http://kenex.co.uk/products/x-ray-shielding/x-ray-table-mounted-shields/lower-body-x-ray; pp. 1-3 Dec. 29, 2016.
[cited by applicant]
Kenex Co. ““Overhead celing mounted shield 350”” obtained from world wide web Dec. 29, 2016; http://kenex.co.uk/products/x-ray-shielding/overhead-suspended-shields-lamps/overhead; pp. 1-3 Dec. 29, 2016.
[cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2021-561838, mailed May 9, 2024, 06 Pages including English Translation.
[cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2023-137479, mailed Apr. 30, 2024, 15 Pages including English Translation.
[cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2023-137479, mailed Aug. 8, 2024, 06 Pages including English Translation.
[cited by applicant]
Notice of Refusal for Japanese Patent Application No. 2021-545836, mailed Mar. 28, 2024, 10 Pages including English Translation.
[cited by applicant]
Notice of Refusal for Japanese Patent Application No. 2021-561838, mailed Nov. 17, 2023, 10 Pages including English Translation.
[cited by applicant]
Office Action received for Australian Patent Application No. 2018422761, mailed on Feb. 12, 2024, 02 pages.
[cited by applicant]
Office Action received for Australian Patent Application No. 2018422761, mailed on Jan. 29, 2024, 03 pages.
[cited by applicant]
Office Action received for Canadian Patent Application No. 3072454, mailed on Feb. 7, 2024, 03 pages.
[cited by applicant]
Office Action received for Canadian Patent Application No. 3072454, mailed on Jul. 21, 2023, 04 pages.
[cited by applicant]
Office Action received for Canadian Patent Application No. 3129066, mailed on Jan. 22, 2024, 04 pages.
[cited by applicant]
Office Action received for European Patent Application No. 18908271.2, mailed on May 9, 2022, 05 pages.
[cited by applicant]
Office Action received for European Patent Application No. 18908271.2, mailed on Nov. 29, 2023, 05 pages.
[cited by applicant]
Office Action received for European Patent Application No. 20710657.6, mailed on Aug. 2, 2024, 05 pages.
[cited by applicant]
Office Action received for European Patent Application No. 20710657.6, mailed on Jan. 15, 2024, 6 Pages.
[cited by applicant]
Office Action received for European Patent Application No. 20725007.7, mailed on Mar. 1, 2024, 4 Pages.
[cited by applicant]
Office Action received for Indian patent Application No. 202147040405, mailed on Apr. 18, 2023, 10 pages.
[cited by applicant]
Search Report & Written Opinion received for Singapore patent Application No. 11202108590W, Completed on Apr. 21, 2023, 11 pages.
[cited by applicant]
Search Report received for Japanese Patent Application No. 2020-530444, mailed on Jun. 15, 2022, 24 pages including English translation.
[cited by applicant]
Second Office Action received for Japanese Patent Application No. 2020-530444, mailed on Nov. 24, 2022, pages including English translation.
[cited by applicant]
Strubel, Christine “International Preliminary Report on Patentability and Written Opinion” European Patent Office pp. 1-9 Feb. 11, 2020.
[cited by applicant]
Torii, Yuki; “Office Action for Japanese Patent Application No. 2020-530444” Japan Patent Office; Jun. 21, 2022; pp. 1-5.
[cited by applicant]
Caluk, Jasmin, “Radiation Principles and Safety,” Intech, Chapter 3, http://dx/doi.org/10.5772/54033, 2013, 20 pages.
[cited by applicant]
Exhibit A: Response Non-Final Office Action for U.S. Ex Part ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Curriculum Vitea of Justin Vahn Lewis, CPA, CVA, CFF (Jan. 2025…
[cited by applicant]
Exhibit B: Response Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651, of U.S. Pat. No. 11,660,056, Schedules, submitted Mar. 17, 2025, 5 pages.
[cited by applicant]
Exhibit C: Response Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Declaration of Justin V. Lewis, submitted Mar. 17, 2025, 44 pa…
[cited by applicant]
Exhibit W: Response Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Declaration of Matthew R. Stelljes, submitted Mar. 17, 2025, 5…
[cited by applicant]
Exhibit AA: Response Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056,WestLaw: United States of Appeals, Federal Circuit:
[cited by applicant]
Exhibit AB: Response Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, WestLaw: United States of Appeals, Federal Circuit:
[cited by applicant]
Exhibit AC: Response Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, WestLaw: United States of Appeals, Federal Circuit:
[cited by applicant]
Supplemental Amendment to Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651, Applicant: Rampart IC, Inc., mailed Mar. 24, 2025, 8 pages.
[cited by applicant]
Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Apr. 7, 2025, 15 pages.
[cited by applicant]
Response to Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 09/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., filed on Jun. 9, 2025,45 pages.
[cited by applicant]
Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Jul. 14, 2025, 19 pages.
[cited by applicant]
Response to Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., submitted Oct. 14, 2025, 125 pages.
[cited by applicant]
Exhibit AG: Response to Final Office Action for U.S. ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Declaration of Dr. Rhain Davies, Applicant: Rampart IC, Inc., submitted…
[cited by applicant]
Table of Authorities and Administrative Reports and Decisions (Exhibit AH-BP) accompanying Response to Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat.…
[cited by applicant]
Advisory Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Oct. 27, 2025, 23 pages.
[cited by applicant]
Notice of Appeal for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., submitted Nov. 14, 2025, 2 pages.
[cited by applicant]
Appeal Brief for U.S. ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., submitted Jan. 14, 2026, 48 pages.
[cited by applicant]
Examiner's Answer for Ex Parte Reexamination for U.S. ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Mar. 2, 2026, 19 pages.
[cited by applicant]
All you need to know about the C-Arm X-Ray Machines (2018) Blog I Trivitron Healthcare Solutions I Medical Device Company—. https://vvww.trivitron. com/blog/aii-you-need-to-know-about-the-c-arm-x-ray-machines-2/, 6 page…
[cited by applicant]
Egg Medical, Inc. (2024). EggNest Complete Brochure. https://eggmedicai.com/wp-content/uploads/2024/10/Eggi'-Jest-Complete-Brochure.pdf, 2 pages.
[cited by applicant]
Global Cardio Vascular Awards Shortlist Page, available at https://globaicardiovascularawards.corn/globalcardiovascularawards2025/en/page/2025-shortiist, 4 pages.
[cited by applicant]
Height—Adjustable, Mobile X-Ray Protective Shield, CSP Medical, Webpage available at: https//csprnedical.corn/height-adjustable-rnobile-x-ray-protective-shield/, accessed Apr. 27, 2024, 3 pages.
[cited by applicant]
Kenex Height Adjustable Mobile Shield, Wardray premise, Webpage available at: hitps://wardray-premise corn/products/product/xrsh-310-b/, accessed Apr. 27, 2024, 2 pages.
[cited by applicant]
RayShield® Adjust-A-Height Barrier, AA.DCO, Webpage available at: https://www.aadcomed.com/product/rayshield-adjust-a-height-barrier/, accessed Apr. 27, 2024, 2 pages.
[cited by applicant]
Anon “Testimonial from Dr. T Eagan, Interventional Cardiologist” Jan. 6, 2021. Available at https://www.youtube. com/watch?v===DU3zi-biw40, 1 page.
[cited by applicant]
Anon 2024. Rampart IC Products. Web page Available at https://www.rampartic.c:om/products, 7pages.
[cited by applicant]
Anon J. “Rampart IC M1128 Protect Yourself, Your Team, and Your Career” last visited Mar. 17, 2025. Available at https://static1.squarespace.com/static/5c7d5feda9ab952d5c179b80/ t!652712121482124ba52840f6/1697059346668/…
[cited by applicant]
Anon. “Rampart IC Tradeshow Video Loop—Feb. 2023.” Mar. 13, 2023. Available at https://www.youtube.com/ watch?v=JdjKpPtPv81, 2 pages.
[cited by applicant]
Anon. “Testimonial from Dr. Mustafa Ahmed, Interventional Cardiologist” Jan. 6, 2021. Available at https://www.youtube.com/watch?v=WowshCz-3ZM, 1 page.
[cited by applicant]
Anon. Rampart M1128 Defender Brochure (2023), 1 page.
[cited by applicant]
Barraclough et al. (2024). Modern radiation safety in the Cardiology Catheter Laboratory, Are we doing enough? Heart Lung and Circulation, 33, 2 pages.
[cited by applicant]
Biswas et al. (2022) TCT-248 Systematic comparison of the efficacy of various radiation protection devices in reducing operator scatter radiation dose in the cardiac Chatherisation Laboratory. Journal of the American Co…
[cited by applicant]
Crowhurst et al., (2023). Trial of a novel radiation shielding device to protect staff in the cardiac catheter laboratory. The American Journal of Cardiology, 203, 7 pages.
[cited by applicant]
Document 1, filed with Document filed May 31, 2024, “Complaint For Patent Infringement”, in Case 1:24-cv-00643-JCG (In The United States District Court For The District Of Delaware), 5 pages.
[cited by applicant]
Document 12, filed with Document filed Jul. 22, 2024, “Egg Medical, Inc.'s Answer And Counterclaims To Plaintiff's Complaint”, in Case 1:24-cv-00643-JCG (In The United States District Court For The District Of Delaware)…
[cited by applicant]
Document 23, filed with Document filed Aug. 21, 2024, “Plaintiff's Answer To Defendant's Counterclaims”, in Case 1:24-cv-00643-JCG (In The United States District Court For The District Of Delaware), 5 pages.
[cited by applicant]
Egg Medical, Inc. (2024). EggNest XR User and Service Manual. https://eggmedical.corn/wp-content/uploads/2024/10/2298rE-User-Manual-XR.pdf; As of Jul. 25, 2024, the Radiation Medical device was not approved for general …
[cited by applicant]
Exhibit B, Document 1-1, filed with Document filed May 31, 2024, “Complaint For Patent Infringement”, in Case 1:24-cv-00643-JCG (In The United States District Court For The District Of Delaware), 6 pages.
[cited by applicant]
Examination Report received for New Zealand Patent Application No. 778798, mailed on Mar. 18, 2025, 05 pages.
[cited by applicant]
First notice of examination for Chinese Patent Application No. 202080026475.1, mailed Jan. 20, 2025, 16 Pages including English Translation.
[cited by applicant]
Global Cardio Vascular Awards Home Page, available at https://globalcardiovasc:ularawards.com/globalcardiovascularawards2025/en/page/horne, 3 pages.
[cited by applicant]
Notice of Reasons for Refusal received for Japanese Patent Application No. 2024-231552, mailed on Feb. 13, 2025, 09 pages including English translation.
[cited by applicant]
Office Action received for Australian Patent Application No. 2020219362, mailed on Jan. 15, 2025, 03 pages.
[cited by applicant]
Office Action received for Australian Patent Application No. 2024200350, mailed on Feb. 18, 2025, 04 pages.
[cited by applicant]
Office Action received for Canadian Patent Application No. 3072454, mailed on Oct. 25, 2024, 03 pages.
[cited by applicant]
Office Action received for European Patent Application No. 20725007.7, mailed on Mar. 4, 2025, 05 pages.
[cited by applicant]
Orme et al. (2015). Occupational Health Hazards of Working in the Interventional Laboratory Journal of the American College of Cardiology, 65(8), 7 pages.
[cited by applicant]
Patel et al. (2024). Implementing a ‘Lead [Apron]-Free’ cardiac catheterization: current status. Current Cardiology Reports, 26(9), 102⋅9 pages.
[cited by applicant]
Rampart Financial Solutions Brochure, 2 pages.
[cited by applicant]
Rampart ic. (Jan. 6, 2021). Testimonial from Dr. Mustafa Ahmed, Interventional Cardiologist YouTube. https://www.youtube.com/watch?v==WowshCz:--3ZM, 1 page.
[cited by applicant]
Rampart ic. (Jan. 6, 2021). Testimonial from Dr. T. Eagan, Interventional Cardiologist. YouTube. https://www.youtube.com/watch?v=DL6zi-biw4o, 1 page.
[cited by applicant]
Request for the submission of an opinion for Korean Patent Application No. 10-2021-7028181, mailed Oct. 4, 2024, 17 Pages including English Translation.
[cited by applicant]
Roguin et al. (2013). Brain and neck tumors among physicians performing interventional procedures The American Journal of Cardiology, 111(9), 5 pages.
[cited by applicant]
Search Report received for Chinese Patent Application No. 202080044365.8, mailed on Apr. 30, 2025, 02 pages.
[cited by applicant]
Smith, L. (2024). “A novel shielding device for cardiac cath labs,” Health Physics, 8 pages.
[cited by applicant]
United States Environmental Protection Agency. (n.d.). Significant Discoveries and the History of Radiation Protection. https://vvwvv.epa.gov/sites/default/files/2018-12/docurnents/significant_discoveries_history_radiat…
[cited by applicant]
Lisko et al. (2023). Radiation Exposure Using Rampart vs Standard Lead Aprons and Shields, Journal of the Society for Cardiovascular Angiography & Interventions, 3:10, 6 pages.
[cited by applicant]
Vlastra, W, et al. (2017) Efficacy of the RADPAD Protection Drape in Reducing Operators' Radiation Exposure in the Catheterization Laboratory. Circulation: Cardiovascular Interventions, 7 pages.
[cited by applicant]
Internet Archive WaybackMachine, Merriam Webster Dictionary, Definition of Mast, https://vW1W.merriam-webster.com/ dictionary/mast, Jun. 8, 2017, 1 page.
[cited by applicant]
Internet Archive WaybackMachine, Merriam Webster Dictionary, Definition of Boom, https://vvvvw.merriam-webster.com/dictionary/boom, May 11, 2017, 1 page.
[cited by applicant]
Office Action received for European Patent Application No. 20710657.6, mailed on Dec. 23, 2024, 6 pages.
[cited by applicant]
Office Action received for Canadian Patent Application No. 3129066, mailed on Nov. 25, 2024, 4 pages.
[cited by applicant]
Order Granting Request for Ex Parte Reexamination for U.S. ReExam Patent Application No. 90/019,649 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Oct. 7, 2024, 16 pages.
[cited by applicant]
Order Granting Request for Ex Parte Reexamination for U.S. ReExam Patent Application No. 90/019,650 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Oct. 7, 2024, 15 pages.
[cited by applicant]
Order Granting Request for Ex Parte Reexamination for U.S. ReExam Patent Application No. 90/019,651, Applicant: Rampart IC, Inc., mailed Oct. 7, 2024, 14 pages.
[cited by applicant]
Decision Sua Sponte Merging Proceedings for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Oct. 17, 2024, 6 pages.
[cited by applicant]
Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Dec. 17, 2024, 13 pages.
[cited by applicant]
Response to Non-Final Office Action for U.S. Ex Parte ReExam Patent Application Nos. 90/019,649, 90/019,650, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., submitted on Mar. 17, 2025, 141 pages.
[cited by applicant]